Anzeige
❌
Mehr »
Donnerstag, 01.10.2026 - Börsentäglich über 12.000 News
Dieselbe Arbeit, dieselbe Rechnung, der vierfache Bruttogewinn
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12HJ9 | ISIN: CA8475771033 | Ticker-Symbol: SD4
Frankfurt
01.10.26 | 08:00
0,695 Euro
-2,80 % -0,020
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SPECTRAL MEDICAL INC Chart 1 Jahr
5-Tage-Chart
SPECTRAL MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,6900,72515:17

Aktuelle News zur SPECTRAL MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.09.Spectral Medical Inc: Spectral receives FDA deficiency letter on PMX approval2
11.09.Stocks in Play: Spectral Medical Inc.1
11.09.Spectral Medical: FDA fordert Nachbesserungen bei Zulassungsantrag für Sepsis-Gerät1
11.09.Spectral Medical receives FDA deficiency letter on sepsis device2
11.09.Spectral Medical Inc.: Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting for PMX PMA796• Company gains further clarity on the additional information required to advance its PMA review • FDA did not request an additional clinical trial following its 100-day review of the PMA application...
► Artikel lesen
SPECTRAL MEDICAL Aktie jetzt für 0€ handeln
07.08.Stocks in Play: Spectral Medical Inc.2
07.08.Spectral Medical Inc.: Spectral Medical Announces Second Quarter 2026 Financial Results and Provides Corporate Update1.282TORONTO, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock...
► Artikel lesen
25.06.Spectral Medical Inc: Spectral Medical files FDA PMA for PMX sepsis therapy1
25.06.Spectral Medical Inc.: Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX259TORONTO, June 25, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock...
► Artikel lesen
09.06.Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders463TORONTO, June 09, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. "Spectral" or the "Company" (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock...
► Artikel lesen
04.06.Spectral Medical Inc: Spectral Medical talks Tigris top-line mortality data1
04.06.Stocks in Play: Spectral Medical Inc.-
29.05.Spectral Medical Inc: Spectral submits FDA PMA for PMX sepsis therapy.2552
29.05.Spectral Medical Inc.: Spectral Medical Announces PMA Submission to U.S. FDA for PMX222TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock...
► Artikel lesen
08.05.Spectral Medical GAAP EPS of -$0.01, revenue of $891M2
08.05.Spectral Medical Inc.: Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update538PMA submission targeted for May 29, 2026 in alignment with FDAVantive commits to additional funding support ahead of PMA acceptance milestone TORONTO, May 08, 2026 (GLOBE NEWSWIRE) -- Spectral Medical...
► Artikel lesen
01.04.Bloom Burton & Co. Inc.: Spectral Medical Inc. Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference641Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - Spectral Medical Inc. (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, will be participating...
► Artikel lesen
26.03.Spectral Medical Inc.: Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update306TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock...
► Artikel lesen
24.03.Spectral Medical Inc.: Spectral Medical and Vantive Announce Publication of Complete Results from Spectral's Tigris Trial in the Lancet Respiratory Medicine426Tigris publication confirms positive results for primary and key secondary endpoints with 95.3% and 99.4% probability of benefit for PMX at 28-day and 90-day mortality After adjusting for baseline...
► Artikel lesen
26.02.Spectral Medical Inc.: Spectral Medical Provides Update on PMA Submission Timing for PMX-20R226TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock...
► Artikel lesen
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1